Ischemia modified albumin levels in intrauterine growth restriction: levels are increased in fetal cord blood but not in maternal blood | Zendy

Ceren Gölbaşı | Zendy; Hakan Gölbaşı | Zendy; Ceysu Kocahakimoğlu Gültekin | Zendy; Varol Gülseren | Zendy; Merve Zeytinli Akşit | Zendy; Burak Bayraktar | Zendy; Ayfer Çolak | Zendy; Cüneyt Eftal Taner | Zendy

Open Access

Ischemia modified albumin levels in intrauterine growth restriction: levels are increased in fetal cord blood but not in maternal blood

Author(s) -

Ceren Gölbaşı,

Hakan Gölbaşı,

Ceysu Kocahakimoğlu Gültekin,

Varol Gülseren,

Merve Zeytinli Akşit,

Burak Bayraktar,

Ayfer Çolak,

Cüneyt Eftal Taner

Publication year - 2022

Publication title -

ginekologia polska

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.4

H-Index - 21

eISSN - 2543-6767

pISSN - 0017-0011

DOI - 10.5603/gp.a2021.0208

Subject(s) - medicine , cord blood , intrauterine growth restriction , ischemia modified albumin , venous blood , albumin , fetus , obstetrics , asphyxia , pregnancy , cord , birth weight , ischemia , physiology , surgery , myocardial ischemia , biology , genetics

In this study, our aim was to determine the differences between intrauterine growth restriction (IUGR) and normal birth weight fetuses in terms of ischemia modified albumin (IMA) levels. For this purpose, we measured ischemia modified albumin levels in the cord blood of fetuses and venous blood of mothers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research